To test whether AMD3100 could inhibit HOXB5-mediated CRC metastasis in vivo, xenograft nude mice were intraperitoneally administrated with AMD3100 or vehicle every two days at a dose of 3 mg/kg from day 8 after implantation. Here, HOXB5 is linked to colorectal carcinoma.